Loss of BAP1 defines a unique subtype of TP53-mutated de novo AML and confers sensitivity to BCL-xL inhibitors
- Journal:
- Blood
- Published:
- Affiliations:
- 2
- Authors:
- 3
| Institutions | Authors | Share |
|---|---|---|
| The George Washington University (GW), United States of America (USA) | 0.67 | |
| Georgetown University Medical Center (GUMC), United States of America (USA) | 0.33 |